Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621619 · ClinicalTrials.gov registry record · Phase 4
IV Acetaminophen as an Analgesic Adjunct
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 159
- Enrollment target
NCT02621619: Completed Phase 4 study, sponsored by Montefiore Medical Center.
NCT02621619 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 159 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02621619, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 159 participants
- Enrollment target
Study Summary
To determine the efficacy of intravenous (IV) acetaminophen as an analgesic adjunct to IV hydromorphone in the treatment of acute severe pain in the elderly Emergency Department (ED) patients.
Primary Outcome
Pain intensity is measured on the numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable). Change in pain intensity is calculated by subtracting pain intensity at 60 minutes from pain intensity at baseline \[e.g. Change = NRS(baseline) - NRS(60 min)\]. Note that a positive change number indicates that pain score decreased after medication was given, while a negative change number indicates that pain score increased after medication was given.
Interventions
- DRUG IV acetaminophen + 0.5 mg IV hydromorphone
- DRUG Normal saline + 0.5 mg IV hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-10 |
| Phase | Phase 4 |
What the finished NCT02621619 record still lists
NCT02621619 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which IV acetaminophen + 0.5 mg IV hydromorphone is the first listed.
NCT02621619 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02621619 about?
NCT02621619 is a clinical study titled "IV Acetaminophen as an Analgesic Adjunct". To determine the efficacy of intravenous (IV) acetaminophen as an analgesic adjunct to IV hydromorphone in the treatment of acute severe pain in the elderly Emergency Department (ED) patients.
What is the current status of trial NCT02621619?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 159 participants. The study started on 2016-03. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02621619?
The interventions under investigation include: IV acetaminophen + 0.5 mg IV hydromorphone (DRUG), Normal saline + 0.5 mg IV hydromorphone (DRUG).
Who is sponsoring clinical trial NCT02621619?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02621619's enrollment target sits among peer trials
159 516th of 2000 higher than 1,485 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia